Library Screening Services

Syd Biotechnologies offers comprehensive cDNA, genomic, and phage display library screening services to support cutting-edge biological research and drug discovery. Leveraging a range of highly specific probes—including cDNA, oligonucleotides, and antibodies—we specialize in identifying and isolating target genetic or protein sequences from complex biological samples.

Our cDNA library screening enables precise detection of gene expression and functional gene analysis. This technique is invaluable for applications in functional genomics, transcriptomics, and disease gene identification. By using cDNA probes, we can identify genes expressed in specific tissues or conditions, providing critical insights into cellular processes and disease mechanisms.

In addition, Syd Biotechnologies performs genomic library screening to explore large segments of the genome, enabling the identification of genes, regulatory elements, and structural variations. Through the use of oligonucleotide probes, we can selectively target and study specific DNA sequences, facilitating discoveries in gene function and regulation.

Our phage display library screening services are designed for the identification of peptides, proteins, or antibodies with high binding affinity to target molecules. This technique involves presenting peptide or antibody fragment libraries on bacteriophage surfaces. Phages that demonstrate strong binding are isolated and amplified, while antibody-based probes enhance specificity—making this method ideal for therapeutic and diagnostic development.

By integrating these advanced screening technologies, Syd Biotechnologies delivers reliable, accurate, and reproducible solutions tailored to your research needs. Whether your focus is on gene expression profiling, protein-protein interactions, or developing targeted therapies, our services provide a strong foundation for meaningful scientific breakthroughs.

Service Highlights

• Quick probe generation via in-house gene synthesis or traditional methods
• Screening of 500,000 to 1,000,000 clones per project
• Multi-tiered screening process: primary, secondary, and tertiary levels
• Use of homologous and heterologous probes
• Support for oligonucleotide and antibody-based probe screening
• High success rate with guaranteed outcomes

Our screening platform is designed to help you quickly identify and isolate clones of interest with precision and confidence.